Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Zagar AJ"" wg kryterium: Autor


Tytuł :
A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia.
Autorzy :
Goldberg RB
Kendall DM
Deeg MA
Buse JB
Zagar AJ
Pinaire JA
Tan MH
Khan MA
Perez AT
Jacober SJ
GLAI Study Investigators
Goldberg, Ronald B
Kendall, David M
Deeg, Mark A
Buse, John B
Zagar, Anthony J
Pinaire, Jane A
Tan, Meng H
Khan, Mehmood A
Perez, Alfonso T
Pokaż więcej
Źródło :
Diabetes Care; Jul2005, Vol. 28 Issue 7, p1547-1554, 8p
Czasopismo naukowe
Tytuł :
Evaluating different strategies for estimating treatment effects in observational studies.
Autorzy :
Zagar AJ; a Eli Lilly and Company , Indianapolis , Indiana , USA.
Kadziola Z; b Eli Lilly and Company , Vienna , Austria.
Lipkovich I; c QuintilesIMS , Durham , North Carolina , USA.
Faries DE; a Eli Lilly and Company , Indianapolis , Indiana , USA.
Pokaż więcej
Źródło :
Journal of biopharmaceutical statistics [J Biopharm Stat] 2017; Vol. 27 (3), pp. 535-553. Date of Electronic Publication: 2017 Feb 07.
Typ publikacji :
Journal Article
MeSH Terms :
Models, Statistical*
Observational Studies as Topic*
Propensity Score*
Computer Simulation ; Humans ; Prognosis ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Impact of Access Site on Bleeding and Ischemic Events in Patients With Non-ST-Segment Elevation Myocardial Infarction Treated With Prasugrel: The ACCOAST Access Substudy.
Autorzy :
Porto I; Interventional Cardiology Unit, Gemelli Hospital, Catholic University of the Sacred Heart, Rome, Italy.
Bolognese L; Cardiovascular and Neurological Department, Azienda Ospedaliera Arezzo, Arezzo, Italy. Electronic address: .
Dudek D; Institute of Cardiology, Jagiellonian University Medical College, University Hospital, Krakow, Poland.
Goldstein P; SAMU and Emergency Department, Lille University Hospital, Lille, France.
Hamm C; Kerckhoff Heart and Thoraxcenter, Bad Nauheim and Medical Clinic I, University of Giessen, Giessen, Germany.
Tanguay JF; Montreal Heart Institute, Université de Montréal, Montreal, Ontario, Canada.
Ten Berg J; Department of Cardiology, St. Antonius Hospital, Nieuwegein, the Netherlands.
Widimský P; Third Medical Faculty of Charles University and University Hospital Royal Vineyards, Prague, Czech Republic.
Le Gall N; inVentiv Health Clinical Canada, Burlington, Ontario, Canada.
Zagar AJ; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana.
LeNarz LA; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana.
Miller D; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana.
Montalescot G; Université Paris 06, ACTION Study Group, INSERM-UMRS 1166, Institut de Cardiologie, Pitié-Salpêtrière University Hospital, Paris, France.
Pokaż więcej
Corporate Authors :
ACCOAST Investigators
Źródło :
JACC. Cardiovascular interventions [JACC Cardiovasc Interv] 2016 May 09; Vol. 9 (9), pp. 897-907.
Typ publikacji :
Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Femoral Artery*
Radial Artery*
Acute Coronary Syndrome/*therapy
Catheterization, Peripheral/*methods
Non-ST Elevated Myocardial Infarction/*therapy
Percutaneous Coronary Intervention/*methods
Platelet Aggregation Inhibitors/*therapeutic use
Prasugrel Hydrochloride/*therapeutic use
Acute Coronary Syndrome/diagnostic imaging ; Aged ; Catheterization, Peripheral/adverse effects ; Coronary Angiography ; Databases, Factual ; Female ; Hemorrhage/chemically induced ; Humans ; Logistic Models ; Male ; Middle Aged ; Multivariate Analysis ; Non-ST Elevated Myocardial Infarction/diagnostic imaging ; Percutaneous Coronary Intervention/adverse effects ; Platelet Aggregation Inhibitors/adverse effects ; Prasugrel Hydrochloride/adverse effects ; Propensity Score ; Proportional Hazards Models ; Prospective Studies ; Punctures ; Recurrence ; Risk Factors ; Stroke/etiology ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Healthcare costs and adherence associated with human regular U-500 versus high-dose U-100 insulin in patients with diabetes.
Autorzy :
Eby EL; Eli Lilly and Company, Indianapolis, Indiana.
Zagar AJ; Eli Lilly and Company, Indianapolis, Indiana.
Wang P; Eli Lilly and Company, Indianapolis, Indiana Biogen Idec, Weston, Massachusetts.
Curtis BH; Eli Lilly and Company, Indianapolis, Indiana.
Xie J; Eli Lilly and Company, Indianapolis, Indiana.
Haldane DC; Eli Lilly and Company, Indianapolis, Indiana.
Idris I; School of Graduate Entry Medicine, University of Nottingham, Nottingham, United Kingdom.
Peters AL; Keck School of Medicine, University of Southern California, Los Angeles, California.
Hood RC; Endocrine Clinic of Southeast Texas, Beaumont, Texas.
Jackson JA; Lilly USA, LLC, Indianapolis, Indiana.
Pokaż więcej
Źródło :
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists [Endocr Pract] 2014 Jul; Vol. 20 (7), pp. 663-70.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Health Care Costs*
Medication Adherence*
Diabetes Mellitus/*drug therapy
Insulin/*administration & dosage
Adult ; Aged ; Female ; Humans ; Insulin Infusion Systems ; Male ; Middle Aged ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Macro- and microvascular outcomes in patients with type 2 diabetes treated with rapid-acting insulin analogues or human regular insulin: a retrospective database analysis.
Autorzy :
Rathmann W; German Diabetes Center, Institute for Biometry and Epidemiology, Leibniz Center for Diabetes Research, Heinrich-Heine University, Duesseldorf, Germany.
Schloot NC; Lilly Deutschland GmbH, Bad Homburg, Germany.
Kostev K; IMS Health, Epidemiology, Frankfurt, Germany.
Reaney M; Lilly Research Centre, Windlesham, Surrey, UK.
Zagar AJ; Eli Lilly and Company, Indianapolis, USA.
Haupt A; Lilly Deutschland GmbH, Bad Homburg, Germany.
Pokaż więcej
Źródło :
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association [Exp Clin Endocrinol Diabetes] 2014 Feb; Vol. 122 (2), pp. 92-9. Date of Electronic Publication: 2014 Feb 20.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Databases, Factual*
Diabetes Mellitus, Type 2/*drug therapy
Hypoglycemic Agents/*administration & dosage
Insulin, Regular, Human/*administration & dosage
Insulin, Short-Acting/*administration & dosage
Microcirculation/*drug effects
Adult ; Age Factors ; Aged ; Diabetes Mellitus, Type 2/epidemiology ; Female ; Follow-Up Studies ; Humans ; Hypoglycemic Agents/adverse effects ; Insulin, Regular, Human/adverse effects ; Insulin, Short-Acting/adverse effects ; Male ; Middle Aged ; Retrospective Studies ; Sex Factors
Czasopismo naukowe
Tytuł :
United States multicenter study of factors predicting the persistence of GH deficiency during the transition period between childhood and adulthood.
Autorzy :
Quigley CA; Lilly Research Laboratories, Indianapolis, IN 46285, USA. .
Zagar AJ
Liu CC
Brown DM
Huseman C
Levitsky L
Repaske DR
Tsalikian E
Chipman JJ
Pokaż więcej
Źródło :
International journal of pediatric endocrinology [Int J Pediatr Endocrinol] 2013 Feb 13; Vol. 2013 (1), pp. 6. Date of Electronic Publication: 2013 Feb 13.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Adherence and dosing frequency of common medications for cardiovascular patients.
Autorzy :
Bae JP; College of Pharmacy, University of Nebraska Medical Center, Nebraska Medical Center, Omaha, NE 68198-6045, USA.
Dobesh PP
Klepser DG
Anderson JD
Zagar AJ
McCollam PL
Tomlin ME
Pokaż więcej
Źródło :
The American journal of managed care [Am J Manag Care] 2012 Mar; Vol. 18 (3), pp. 139-46.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cardiovascular Diseases/*drug therapy
Medication Adherence/*statistics & numerical data
Age Factors ; Anti-Arrhythmia Agents/therapeutic use ; Anticholesteremic Agents/therapeutic use ; Antihypertensive Agents/therapeutic use ; Chronic Disease ; Female ; Health Status Indicators ; Humans ; Hypoglycemic Agents/therapeutic use ; Insurance Claim Review ; Male ; Retrospective Studies ; Sex Factors ; Time Factors ; United States
Czasopismo naukowe
Tytuł :
Cost-effectiveness of prasugrel in a US managed care population.
Autorzy :
Mauskopf JA; RTI Health Solutions, Research Triangle Park, NC 27709, USA. />Graham JB
Bae JP
Ramaswamy K
Zagar AJ
Magnuson EA
Cohen DJ
Meadows ES
Pokaż więcej
Źródło :
Journal of medical economics [J Med Econ] 2012; Vol. 15 (1), pp. 166-74. Date of Electronic Publication: 2011 Nov 18.
Typ publikacji :
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Managed Care Programs*
Piperazines/*economics
Thiophenes/*economics
Acute Coronary Syndrome/drug therapy ; Aged ; Aspirin/therapeutic use ; Clopidogrel ; Cost Control ; Cost-Benefit Analysis/methods ; Drug Therapy, Combination/economics ; Female ; Humans ; Interviews as Topic ; Male ; Middle Aged ; Models, Economic ; Outcome Assessment, Health Care/methods ; Piperazines/therapeutic use ; Platelet Aggregation Inhibitors/economics ; Platelet Aggregation Inhibitors/therapeutic use ; Prasugrel Hydrochloride ; Thiophenes/therapeutic use ; Ticlopidine/analogs & derivatives ; Ticlopidine/economics ; Ticlopidine/therapeutic use ; United States
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies